Adrien Herledan

Adrien Herledan

UNVERIFIED PROFILE

Are you Adrien Herledan?   Register this Author

Register author
Adrien Herledan

Adrien Herledan

Publications by authors named "Adrien Herledan"

Are you Adrien Herledan?   Register this Author

13Publications

639Reads

45Profile Views

Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.

Eur J Med Chem 2019 Oct 24;179:557-566. Epub 2019 Jun 24.

Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France; Institut Universitaire de France, F- 75231, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2019.06.057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718346PMC
October 2019

New active leads for tuberculosis booster drugs by structure-based drug discovery.

Org Biomol Chem 2017 Dec;15(48):10245-10255

Department of Chemistry, Durham University, South Road, Durham DH1 3LE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c7ob00910kDOI Listing
December 2017

Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme.

Eur J Med Chem 2015 Jan 4;90:547-67. Epub 2014 Dec 4.

INSERM U761 Biostructures and Drug Discovery, Lille, France; Lille F-59000, France; Institut Pasteur de Lille, IFR 142, Lille F-59000, France; PRIM, Lille F-59000, France; CDithem Platform/IGM, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2014.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325277PMC
January 2015

Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.

J Biomol Screen 2014 Aug 8;19(7):1035-46. Epub 2014 May 8.

CDithem. Faculté de Pharmacie, Lille, France; www.CDithem.com INSERM U761, Biostructures and Drug Discovery, Université de Lille, Institut Pasteur de Lille, IFR 142, PRIM, Lille, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087057114534070DOI Listing
August 2014

Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.

Hum Mutat 2009 Oct;30(10):1419-27

Institut National de la Santé et de la Recherche Médicale, U582, Institut de Myologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.21086DOI Listing
October 2009

Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes.

Mol Endocrinol 2006 May 26;20(5):1035-47. Epub 2006 Jan 26.

Institut National de la Santé et de la Recherche Médicale Unité 540, Endocrinologie Moléculaire et Cellulaire des Cancers and Université de Montpellier I, 60 rue de Navacelles, 34090 Montpellier, France.

View Article

Download full-text PDF

Source
https://academic.oup.com/mend/article-lookup/doi/10.1210/me.
Publisher Site
http://dx.doi.org/10.1210/me.2005-0227DOI Listing
May 2006